Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Geron Corporation

http://www.geron.com

Latest From Geron Corporation

Reddy’s Exclusivity End Allows Teva, Natco To Match Full US Revlimid Suite

Teva has moved fast to match Dr Reddy’s Laboratories’ complete six-strength offering of generic Revlimid (lenalidomide) products in the US.

Approvals Launches

Silicon Valley Bank’s Failure Rattles Investors In Biopharma Sector

Investment bank analysts, VC funds and biopharma companies all sought to calm investors’ nerves as a go-to financial institution for tech and biotech collapsed.

Financing Companies

Biogen Launches Lucentis Biosimilar Byooviz In Canada

Biogen has launched the Samsung Bioepis-developed Byooviz version of Lucentis in Canada, marking the first and only ranibizumab biosimilar to be approved and introduced in the market.

Launches Canada

Natco Continues Para IV Charge With $1.2bn Lynparza, FTF ‘Possible’

Indian firm Natco is continuing to build its US pipeline and ex-India geographic presence, the company’s management told investors, in the wake of announcing a major paragraph IV patent challenge opportunity.

Generic Drugs Intellectual Property
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • TA Therapeutics, Ltd.
UsernamePublicRestriction

Register